Team:UCLouvain/Notebook

 Notebook


OUR LONG SUMMER!



  • Installation and cleaning of the academic laboratory
  • verification of equipments (calibration…)





Week 1

  • start of interlab’s experiments

Week 2

  • design of our pBullet plasmid, capable of conjugation and recombination of a Crispr/Cas9 system, targeting RFP and AmpR gene, with a biosafety component (Lambda-Pir dependent)
  • Interlab

Week 3

  • Complete modification of our plasmid’s design
  • Interlab

Week 4

  • Culture and Minipreps of the pCas plasmid
  • Enzyme digestion of Cas9 gene ( promoter and terminator too)
  • Phenol/Chloroform purification of the Cas9 cassette
  • Preparation of electrocompetent cells (S17-1) to receive our plasmid
  • Order (at IDT) for our synthetic sgRNA part (targeting RFP and AmpR gene)
  • Interlab





Week 1

  • Culture and phenol/Chlo purification of the plasmid pK18mob (our mobilizable plasmid, which will receive the Cas9 and sgRNA)
  • Minipreps of the pK18mob plasmid
  • PCR to amplify the Cas9 gene (with tracer part) of pCAS plasmid

Week 2

  • Single/Double enzymatic digestion of pK18mob plasmid to check
  • Minipreps, Proteinase K and Phenol/Chloroform purification after a PCR of Cas9
  • Double enzymatic digestion of the Cas9 cassette
  • Ligation of the Cas9 cassette into the pK18mob plasmid + verification of the result with enzymatic digestion and PCR
  • Minipreps of the new plasmid (pK18mob+Cas9 cassette)
  • Transformation of the new plasmid into the pUC19 strain
  • PCR and purification of the Cas9 cassette (with the tracer part of the Cas9)
  • Receipt of the IDT order (our synthetic sgRNA targeting RFP and AmpR)

Week 3

  • Stability test of our receiver plasmid (low copy plasmid pSB4K5_BBa_J04450)
  • Enzymatic digestion (linearization) of our biosafety plasmid (pSW23T carrying R6K Ori and Lambda-Pir dependent)
  • Enzymatic digestion of the Cas9 cassette (tracer version) and ligation into pK18mob plasmid
  • Verification of the sgRNA (received from IDT) by Miniprep and double enzymatic digestion
  • Transformation of the sgRNA (with and without NheI site) (note: 3 of the 6 orders received from IDT was empty !)
  • Transformation of the new pK18mob into chemically competent cells
  • Glycerol stock and Minipreps of the sgRNA
  • Glycerol stock and Minipreps of the pK18mob with Cas9 cassette (tracer version)
  • Verification by enzymatic digestion of the plasmid insertion

Week 4

  • Double enzymatic digestion of the sgRNA targeting RFP and the new pK18mob (with Cas9 cassette)
  • Ligation of the sgRNA targeting RFP with the new pK18mob (with Cas9 cassette)
  • First test to check the conjugation protocols
  • Minipreps and gel verification of the sgRNA targeting RFP and the new pK18mob (with Cas9 cassette)
  • Sequencing of the pK18mob + Cas9 cassette and sgRNA (with and without NheI)
  • Transformation of the new plasmid (pK18mob + Cas9 cassette + sgRNA targeting RFP)
  • Verification of all our strain with antibiograms
  • PCR modification, minipreps and gel verification of the plasmid pSW23T to modify the MCS





Week 1

  • Sequencing of the pK18mob + Cas9 cassette (tracer version)
  • Concentration verification (Nanodrop) of our killer plasmid (targeting RFP gene)
  • Transformation into S17-1 of our killer plasmid (targeting RFP gene)
  • Verification of efficiency (PCR diagnostic, enzymatic digestion, gel) of the BaeI enzyme (for our new biobrick system)
  • PCR diagnostic of our killer plasmid (two version of the Cas9 with and without tracer)
  • New clonage approach test for the sgRNA (NheI version) with pGem T-easy
  • Verification test of the efficiency of the Cas9 and sgRNA in pK18mob plasmid + stability test of our killer plasmid with our reporter plasmid.
  • Electroporation and PCR of our killer plasmid in S17-1 Lambda-Pir
  • PCR diagnostic of the pGem T easy
  • Receipt of order from IDT of the sgRNA targeting AmpR gene.
  • Enzymatic digestion and verification of the sgRNA targeting AmpR gene.
  • Ligation and electroporation of our plasmid pK18mob with Cas9 cassette and the new sgRNA targeting AmpR gene.
  • Interruption of all manipulation concerning both sgRNA (with and without NheI site) and the Cas9_tracer_version. (No DNA in the IDT order)

Week 2

  • PCR verification after transformation of our new plasmid targeting AmpR gene + glycerol stock
  • Minipreps and enzymatic digestion to check the presence of the sgRNA
  • Verification of Crispr/Cas9 efficiency of our killer plasmid
  • Enzymatic digestion, ligation, electroporation and verification of our biosafety plasmid (pSW23T targeting RFP and AmpR gene)
  • Transformation + verification of our differents plasmids in E. coli strains.
  • Sequencing of our killer plasmid targeting AmpR gene.
  • First test of conjugation in a liquid phase
  • Cleaning of the academic laboratory

Week 3

  • Gibson + PCR amplification of pUC19
  • Verification of the IDT order (our new biobrick)
  • Transformation and PCR verification of the insertion of the Cas9+sgRNA cassette in the new pSW23T.
  • Verification of the new IDT order (sgRNA with GFP reporter gene) : No DNA.
  • Second verification of the efficiency of our Crispr/cas9 system
  • Test of selection of our donor and receiver strain over NAC.
  • Conjugation test 2 in liquid phase
  • Conjugation test in plate with IPTG/X-Gal system
  • Gel control of the last conjugation

Week 4

  • Conjugation test of our donor strain (S17-1 with our killer plasmid targeting AmpR gene) and a E.coli strain carrying TEM1 gene in his chromosome.
  • Enzymatic digestion and verification of a new reporter plasmid (with GFP AmpR and pSC101)
  • Conjugation test with differents donor and receiver strains
  • Verification of conjugation efficiency between donor strain and receiver strain, with IPTG/X-Gal system





Week 1

  • preparation of strains for fluorescent microscopy
  • Fluorescent microscopy assay
  • Conjugation “in plate” test with differents donor and receiver strains

Week 2

  • Quantitative conjugation “in plate” test with differents donor and receiver strains
  • Conjugation “cross” test between our donor and receiver strains.
  • Wiki writting

  • Wiki writting and preparation of the poster
  • Cleaning of the L2 laboratory